Seerlinq develops AI solutions for non-invasive diagnostics and personalized treatment optimization in healthcare.
Seerlinq has raised $982K in total funding. The most recent round was Seed. The last funding was announced in July 2023.
Seerlinq's investors include Vision Ventures.
Seerlinq is headquartered in Trnava, Slovakia (Slovak Republic).
Seerlinq develops AI solutions for non-invasive diagnostics and personalized treatment optimization in healthcare.
Seerlinq is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seerlinq — Funding & Investors." VCBacked, July 3, 2023, https://www.vcbacked.co/company/seerlinq. Accessed August 14, 2026.
VCBacked. (2023). Seerlinq — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/seerlinq
{{cite web |title=Seerlinq — Funding & Investors |url=https://www.vcbacked.co/company/seerlinq |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated